Efficacy of Intravenous Oxytocin to Speed Recovery After THA

Phase 2 Enrolling by invitation 80 enrolled Wake Forest University Health Sciences National Institute of Neurological Disorders and Stroke (NINDS) · collab

RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to test whether perioperative intravenous (IV) oxytocin compared to placebo results in faster recovery in disability as measured by daily steps over 56 days after Total Hip Arthroplasty (THA).

Timeline

Start: 2026-07
Primary completion: 2027-12
Completion: 2027-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Oxytocin	Peptide	26 ug	Intravenous

Indications

No indication recorded.